Schedule 13G ownership disclosure
LENZ THERAPEUTICS INC
Common Stock · CUSIP: 52635N103
Event date: 2025-09-30
- Filing-level shares
- 1,442,864
- Percent of class
- 5.1%
- BlackRock, Inc.
Shares: 1,442,864 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-002599
- Form type
- SCHEDULE 13G
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Oct 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership